2nd Feb 2024 14:15
Haleon plc: Director Declaration
2 February 2024: In accordance with paragraph 9.6.14R of the Listing Rules of the UK Financial Conduct Authority, Haleon plc (LSE/NYSE: HLN) announces that Brian McNamara, Group Chief Executive Officer, has been appointed to the Board of Mondel?z International, Inc. (Nasdaq: MDLZ), as a Non-Executive Director with effect from 1 February 2024.
There is no further information to be disclosed in respect of paragraph 9.6.14.
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
Related Shares:
Haleon